Study reports blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

byLouisiana State UniversityCredit:Frontiers in ImmunologyDOI: 10.3389/fimmu.2022.987298A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strateg

Updated on: January 16,2024

Study reports blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

byLouisiana State UniversityCredit:Frontiers in ImmunologyDOI: 10.3389/fimmu.2022.987298A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strateg

Updated on:January 16,2024

Researchers develop tool that reduces errors in stem cell transplant reporting

by Children's Hospital of PhiladelphiaCredit: CC0 Public DomainResearchers at Children's Hospital of Philadelphia (CHOP) have developed a custom-built application to automate determinatio

Updated on: February 20,2024

Researchers develop tool that reduces errors in stem cell transplant reporting

by Children's Hospital of PhiladelphiaCredit: CC0 Public DomainResearchers at Children's Hospital of Philadelphia (CHOP) have developed a custom-built application to automate determinatio

Updated on:February 20,2024

Ryan Reynolds has urged 45-year-olds to screen for bowel cancer. But the case for screening in your 40s isn't clear cut

by Katy Bell and Paul Glasziou,The ConversationCredit: AI-generated imageLast week, actors Ryan Reynolds and Rob McElhenney released avideo of themselves getting colonoscopiesto enco

Updated on: January 03,2024

Ryan Reynolds has urged 45-year-olds to screen for bowel cancer. But the case for screening in your 40s isn't clear cut

by Katy Bell and Paul Glasziou,The ConversationCredit: AI-generated imageLast week, actors Ryan Reynolds and Rob McElhenney released avideo of themselves getting colonoscopiesto enco

Updated on:January 03,2024

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Updated on: August 03,2024

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Updated on:August 03,2024

New precision therapy for bile duct cancer extends patients' lives

byUniversity College LondonCredit: Pixabay/CC0 Public DomainA new personalized cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international

Updated on: January 12,2024

New precision therapy for bile duct cancer extends patients' lives

byUniversity College LondonCredit: Pixabay/CC0 Public DomainA new personalized cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international

Updated on:January 12,2024

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on: March 06,2024

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on:March 06,2024

AI predicts cancer patients' symptoms

by University of SurreyCredit: CC0 Public DomainDoctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to predict symptoms and their se

Updated on: March 06,2024

AI predicts cancer patients' symptoms

by University of SurreyCredit: CC0 Public DomainDoctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to predict symptoms and their se

Updated on:March 06,2024

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys

Updated on: March 06,2024

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys

Updated on:March 06,2024

Social media can boost melanoma detection, research suggests

by Leila Okahata,University of OregonExamples of knowledge, self-efficacy, and control messages. Credit:JID Innovations(2023). DOI: 10.1016/j.xjidi.2023.100253Early detection is key

Updated on: March 30,2024

Social media can boost melanoma detection, research suggests

by Leila Okahata,University of OregonExamples of knowledge, self-efficacy, and control messages. Credit:JID Innovations(2023). DOI: 10.1016/j.xjidi.2023.100253Early detection is key

Updated on:March 30,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on: March 30,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on:March 30,2024

Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

by Adam Pope,University of Alabama at BirminghamProtein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. Th

Updated on: February 18,2024

Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

by Adam Pope,University of Alabama at BirminghamProtein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. Th

Updated on:February 18,2024

Startup helps identify patients at risk for hereditary cancers

by Greta Guest,University of MichiganCredit: CC0 Public DomainUniversity of Michigan startup InheRET Inc. has launched an online program that helps identify patients at risk for hereditary cance

Updated on: March 08,2024

Startup helps identify patients at risk for hereditary cancers

by Greta Guest,University of MichiganCredit: CC0 Public DomainUniversity of Michigan startup InheRET Inc. has launched an online program that helps identify patients at risk for hereditary cance

Updated on:March 08,2024